Cat.#: ACPP-1759
Despition | CDNF Rat Recombinant |
SIZE | 5 µg |
Purity | > 97.0% (SDS-PAGE) |
Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored and desiccated below -18°C. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
ACPP-1444 | Human VAMP2 Protein (AC1444) | 5 µg | inquiry |
ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
ACPP-1091 | BMP11 Blocking Peptide (AC1091) | 250 µg | inquiry |
ACPP-1089 | Human GDF11 Protein (AC1089) | 5 µg | inquiry |
ACPP-1129 | Recombinant Human GLP-1R Protein (Fc Tag) (AC1129) | 50 µg | inquiry |
ACPP-1810 | Rat LIF Protein (AC1810) | 2 µg | inquiry |
ACPP-1172 | Native Human Prostate Specific Antigen (Functional) - Low endotoxin (AC1172) | 1 mg | inquiry |
ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
ACPP-1184 | MSX1 Blocking Peptide (AC1184) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.